ArticleDrug discovery today2022

Regulatory oversight on the use of experimental therapies during a pandemic: The case of early access to convalescent plasma therapy in three LMICs.

Rosemarie Bernabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.